SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 60MG
Product details
Registration number: SIN15170P
Classification: Prescription Only
Active ingredients: Pasireotide pamoate 82.26mg eqv Pasireotide
Strength: 60mg
Dosage form: INJECTION, POWDER, FOR SUSPENSION
Route: INTRAMUSCULAR
Registrant: PHARM-D SINGAPORE PRIVATE LIMITED
ATC code: H01CB05
HSA approval date: 2 February 2017
Manufacturer(s):
- Recordati AG Rare Diseases Branch (manufacture of bulk powder)
- Novartis Pharmaceutical Manufacturing GmbH (primary packager of Powder)
- Abbott Biologicals B.V. (manufacture, primary and secondary packager for solvent)
- Synergy Health Daniken AG (sterilization site)
Manufacturing country/countries: SWITZERLAND; AUSTRIA; NETHERLANDS
What are the HSA registration number and classification for SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 60MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15170P
Classification: Prescription Only
What active ingredients and strength are recorded for SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 60MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Pasireotide pamoate 82.26mg eqv Pasireotide
Strength: 60mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 60MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SUSPENSION
Route: INTRAMUSCULAR
Who is the recorded registrant for SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 60MG?
According to the HSA dataset updated 7 August 2026:
Registrant: PHARM-D SINGAPORE PRIVATE LIMITED
Which manufacturers and countries are listed for SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 60MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Recordati AG Rare Diseases Branch (manufacture of bulk powder)
- Novartis Pharmaceutical Manufacturing GmbH (primary packager of Powder)
- Abbott Biologicals B.V. (manufacture, primary and secondary packager for solvent)
- Synergy Health Daniken AG (sterilization site)
Manufacturing country/countries: SWITZERLAND; AUSTRIA; NETHERLANDS
Where can I look up SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 60MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15170P or the exact product name SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 60MG. The general register link does not preselect this product.
What are the source dates for this SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 60MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 60MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15170P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)